Success Story: EB-1A Approval for a Research Scientist in the field of Genetic Engineering
Client’s Testimonial:
Many thanks for your great job! I will definitely recommend your firm to my friends!On November 4th, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Research Scientist in the field of Genetic Engineering (Approval Notice)
General Field: Genetic Engineering
Position at the Time of Case Filing: Research Scientist
National Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Ohio
Approval Notice Date: November 4, 2013
Processing Time: 5 months, 7 days
Case Summary:
The client in this case was a Research Scientist from China in the field of genetic engineering. His work had primarily focused on analyzing two classes of small non-coding RNAs: small interfering RNA (siRNA) and microRNA. His work had resulted in at least 6 peer-reviewed scientific articles. At the time that his case was filed, his publications had accumulated at least 109 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had conducted 19 paper reviews for 9 journals related to the field of genetic engineering. Of his accomplishments, one of his independent recommenders remarked, “Not only has [his] research contributed to the understanding of mechanisms of gene silencing in plants, but it also suggests strategies for engineering improved virus resistance in genetic engineered crops. These strategies have the potential to be applied to the production disease-resistant food crops, thereby alleviating famine and hunger in farming-dependent regions of the world. The high profile study published in the [journal] in 2007 elevated [him] to the top of his field, and he is now an internationally-recognized plant pathologists.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of genetic engineering, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 160 days.

